SARS-CoV-2: A synergy to the Alzheimer's disease
- PMID: 39998800
- DOI: 10.1007/s13365-025-01247-w
SARS-CoV-2: A synergy to the Alzheimer's disease
Abstract
COVID-19 was a nightmare in humankind's history that challenged our advanced medical technology. All credit goes to the researchers who played a crucial role in curbing COVID-19 and proved our medical technology supremacy. However, COVID-19 has left some mysterious scars on human well-being. It is believed that COVID-19 has a significant negative impact on various cardiovascular (CVS) and central nervous system (CNS) diseases, especially in the case of CNS diseases like Alzheimer's. Surprisingly, COVID-19 affects the respiratory system, whereas Alzheimer's disease (AD) alters brain function. To explain this phenomenon, several hypotheses were proposed, but the mechanism needs to be clearly understood. Another critical thing to be concerned about is that COVID-19 will worsen pre-existing conditions and lead to the onset of AD. In the race to curb COVID-19, the invention of vaccines was speeded up, and it is necessary to fight against COVID-19. However, postvaccination follow-up is mandatory when an individual is a victim of AD. In this review article, we compiled the various dreadful effects of the COVID-19 virus on AD, the Post effects of the virus on AD, and the effect of the COVID-19 vaccination on AD. This article provides a new direction for research concerning COVID-19 and AD.
Keywords: Alzheimer’s disease; COVID 19; Dreadful effect of SARS CoV 2 virus on Alzheimer’s disease; Impact of COVID 19 vaccination on AD; Post COVID 19 effect on AD.
© 2025. The Author(s) under exclusive licence to The Journal of NeuroVirology, Inc.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
References
-
- Arbour N, Côté G, Lachance C et al (1999) Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol 73:3338–3350. https://doi.org/10.1128/JVI.73.4.3338-3350.1999 - DOI - PubMed - PMC
-
- Atkins JL, Masoli JAH, Delgado J et al (2020) Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank Community Cohort. J Gerontol-Ser A Biol Sci Med Sci 75:2224–2230. https://doi.org/10.1093/GERONA/GLAA183 - DOI
-
- Bakker ED, van der Pas SL, Zwan MD et al (2023) Steeper memory decline after COVID-19 lockdown measures. Alzheimers Res Ther 15:. https://doi.org/10.1186/S13195-023-01226-5
-
- Barbosa LC, Gonçalves TL, de Araujo LP et al (2021) Endothelial cells and SARS-CoV-2: An intimate relationship. Vascul Pharmacol 137:. https://doi.org/10.1016/j.vph.2021.106829
-
- Beyerstedt S, Casaro EB, Rangel ÉB (2021) COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis 40:905. https://doi.org/10.1007/S10096-020-04138-6 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
